A comparison between diuretics and angiotensin- receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial
Carregando...
Data
2011
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background: Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor.
The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated.
Angiotensin-receptor blockers (ARB) have been the preferential drugs in the management of hypertension
worldwide, despite the absence of any consistent evidence of advantage over older agents, and the concern that
they may be associated with lower renal protection and risk for cancer. Diuretics are as efficacious as other agents,
are well tolerated, have longer duration of action and low cost, but have been scarcely compared with ARBs.
A study comparing diuretic and ARB is therefore warranted.
Methods/design: This is a randomized, double-blind, clinical trial, comparing the association of chlorthalidone and
amiloride with losartan as first drug option in patients aged 30 to 70 years, with stage I hypertension. The primary
outcomes will be variation of blood pressure by time, adverse events and development or worsening of
microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal
cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new subclinical atherosclerosis and
sudden death. The study will last 18 months. The sample size will be of 1200 participants for group in order to
confer enough power to test for all primary outcomes. The project was approved by the Ethics committee of each
participating institution.
Discussion: The putative pleiotropic effects of ARB agents, particularly renal protection, have been disputed, and
they have been scarcely compared with diuretics in large clinical trials, despite that they have been at least as
efficacious as newer agents in managing hypertension. Even if the null hypothesis is not rejected, the information
will be useful for health care policy to treat hypertension in Brazil.
Descrição
Palavras-chave
Citação
FUCHS, Flavio D. et al. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial. Trials, London, v. 12, n. 53, p. 1-5, 2011.